Pharmadrug's market cap is currently C$1.60M. The company's EPS TTM is C$-0.215; its P/E ratio is ―; Pharmadrug is scheduled to report earnings on May 6, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	C$ 0.00	C$ 0.00	C$ 494.99K	C$ 683.67K	C$ 610.58K
Gross Profit	C$ -26.22K	C$ -2.26K	C$ 100.86K	C$ 182.04K	C$ 253.25K
Operating Income	C$ -1.34M	C$ -2.43M	C$ -5.11M	C$ -3.82M	C$ -5.09M
EBITDA	C$ -1.34M	C$ -2.34M	C$ -4.21M	C$ -4.28M	C$ -5.73M
Net Income	C$ -13.20M	C$ -3.06M	C$ -5.87M	C$ -5.51M	C$ -6.54M
Balance Sheet
Cash & Short-Term Investments	C$ 423.06K	C$ 329.24K	C$ 1.30M	C$ 4.40M	C$ 73.68K
Total Assets	C$ 1.20M	C$ 12.11M	C$ 19.52M	C$ 13.69M	C$ 10.38M
Total Debt	C$ 1.77M	C$ 1.42M	C$ 866.37K	C$ 1.13M	C$ 3.12M
Net Debt	C$ 1.36M	C$ 1.41M	C$ -91.62K	C$ -1.01M	C$ 3.05M
Total Liabilities	C$ 2.66M	C$ 3.28M	C$ 2.66M	C$ 3.12M	C$ 5.92M
Stockholders' Equity	C$ -1.70M	C$ 8.84M	C$ 16.87M	C$ 9.33M	C$ 2.98M
Cash Flow
Free Cash Flow	C$ -671.88K	C$ -2.26M	C$ -4.17M	C$ -1.43M	C$ -2.36M
Operating Cash Flow	C$ -671.88K	C$ -2.26M	C$ -4.13M	C$ -1.41M	C$ -2.34M
Investing Cash Flow	C$ 995.04K	C$ 77.58K	C$ 1.48M	C$ 3.78M	C$ -7.32M
Financing Cash Flow	C$ 225.51K	C$ 843.25K	C$ 776.97K	C$ 132.24K	C$ 9.51M

Currency in CAD

Pharmadrug Earnings and Revenue History

Income Statement >

Pharmadrug Debt to Assets

Balance Sheet >

Pharmadrug Cash Flow

Cash Flow >

Pharmadrug Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing